Inventor · disambiguated record
Frederick L. Baehner
Also filed as: BAEHNER FREDERICK L
5 granted patents·6 pending applications·7 citations·filing 2009–2024
72Inventor score
Top patents by PatentIndex Score
11 records- 0186US12412642B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2023·Granted Sep 9, 2025·0 cites·20 claims
- 0286US10260104B2Method for using gene expression to determine prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2015·Granted Apr 16, 2019·2 cites·11 claims
- 0386US9551034B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerCOWENS WAYNE·Filed 2011·Granted Jan 24, 2017·5 cites·12 claims
- 0485US2025129432A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerMDXHEALTH SA·Filed 2024·Application pending·0 cites
- 0578US2022396842A1Method for using gene expression to determine prognosis of prostate cancerMDXHEALTH SA·Filed 2022·Application pending·0 cites
- 0674US11776664B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 0772US2019249260A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2019·Application pending·0 cites
- 0869US2020255911A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 0964US10892038B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2016·Granted Jan 12, 2021·0 cites·22 claims
- 1057US2012028264A1Method for using gene expression to determine prognosis of prostate cancerSHAK STEVEN·Filed 2011·Application pending·0 cites
- 1156US2010151463A1Method for Determining the Likelihood of Response to HER2 InhibitorsBAEHNER FREDERICK L·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederick L. Baehner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →